nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—skin cancer	0.515	1	CbGaD
Magnesium salicylate—ALB—Vismodegib—skin cancer	0.163	0.466	CbGbCtD
Magnesium salicylate—ALB—Vemurafenib—skin cancer	0.129	0.368	CbGbCtD
Magnesium salicylate—ALB—Fluorouracil—skin cancer	0.0578	0.166	CbGbCtD
Magnesium salicylate—Warts—Imiquimod—skin cancer	0.0138	0.124	CcSEcCtD
Magnesium salicylate—Skin papilloma—Vemurafenib—skin cancer	0.00573	0.0515	CcSEcCtD
Magnesium salicylate—Skin papilloma—Imiquimod—skin cancer	0.00489	0.044	CcSEcCtD
Magnesium salicylate—Localized exfoliation—Bleomycin—skin cancer	0.0042	0.0378	CcSEcCtD
Magnesium salicylate—PTGS2—leg—skin cancer	0.00246	0.125	CbGeAlD
Magnesium salicylate—PTGS2—hindlimb—skin cancer	0.0022	0.112	CbGeAlD
Magnesium salicylate—Abdominal pain upper—Vismodegib—skin cancer	0.002	0.018	CcSEcCtD
Magnesium salicylate—Stinging—Imiquimod—skin cancer	0.00197	0.0177	CcSEcCtD
Magnesium salicylate—PTGS2—appendage—skin cancer	0.00189	0.0959	CbGeAlD
Magnesium salicylate—PTGS2—skin epidermis—skin cancer	0.00157	0.0797	CbGeAlD
Magnesium salicylate—Skin exfoliation—Imiquimod—skin cancer	0.00152	0.0137	CcSEcCtD
Magnesium salicylate—Trisalicylate-choline—PTGS2—skin cancer	0.00141	0.314	CrCbGaD
Magnesium salicylate—Duodenal ulcer—Docetaxel—skin cancer	0.00131	0.0118	CcSEcCtD
Magnesium salicylate—Dysgeusia—Vismodegib—skin cancer	0.00129	0.0116	CcSEcCtD
Magnesium salicylate—Heartburn—Fluorouracil—skin cancer	0.00128	0.0115	CcSEcCtD
Magnesium salicylate—PTGS1—endothelium—skin cancer	0.00119	0.0605	CbGeAlD
Magnesium salicylate—Lethargy—Imiquimod—skin cancer	0.00118	0.0106	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Dactinomycin—skin cancer	0.00115	0.0104	CcSEcCtD
Magnesium salicylate—PTGS2—endothelium—skin cancer	0.00114	0.0579	CbGeAlD
Magnesium salicylate—PTGS1—blood vessel—skin cancer	0.0011	0.0558	CbGeAlD
Magnesium salicylate—Stinging—Fluorouracil—skin cancer	0.00109	0.00976	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Bleomycin—skin cancer	0.00108	0.00972	CcSEcCtD
Magnesium salicylate—PTGS2—blood vessel—skin cancer	0.00105	0.0534	CbGeAlD
Magnesium salicylate—Hearing impaired—Temozolomide—skin cancer	0.001	0.00902	CcSEcCtD
Magnesium salicylate—Oesophagitis—Dactinomycin—skin cancer	0.000965	0.00867	CcSEcCtD
Magnesium salicylate—Dyspepsia—Vismodegib—skin cancer	0.00095	0.00854	CcSEcCtD
Magnesium salicylate—Decreased appetite—Vismodegib—skin cancer	0.000938	0.00843	CcSEcCtD
Magnesium salicylate—Heartburn—Docetaxel—skin cancer	0.000923	0.00829	CcSEcCtD
Magnesium salicylate—Constipation—Vismodegib—skin cancer	0.000923	0.00829	CcSEcCtD
Magnesium salicylate—Pain—Vismodegib—skin cancer	0.000923	0.00829	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Temozolomide—skin cancer	0.000922	0.00829	CcSEcCtD
Magnesium salicylate—Burning sensation—Docetaxel—skin cancer	0.000914	0.00822	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Temozolomide—skin cancer	0.000912	0.0082	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Vemurafenib—skin cancer	0.000887	0.00798	CcSEcCtD
Magnesium salicylate—Salicylate-sodium—PTGS2—skin cancer	0.000854	0.19	CrCbGaD
Magnesium salicylate—Erythema—Vemurafenib—skin cancer	0.000817	0.00734	CcSEcCtD
Magnesium salicylate—Oesophagitis—Fluorouracil—skin cancer	0.000804	0.00723	CcSEcCtD
Magnesium salicylate—Dysgeusia—Vemurafenib—skin cancer	0.0008	0.00719	CcSEcCtD
Magnesium salicylate—PTGS1—nipple—skin cancer	0.000794	0.0404	CbGeAlD
Magnesium salicylate—Lethargy—Dactinomycin—skin cancer	0.000782	0.00703	CcSEcCtD
Magnesium salicylate—Deafness—Temozolomide—skin cancer	0.000775	0.00697	CcSEcCtD
Magnesium salicylate—Pruritus—Vismodegib—skin cancer	0.000763	0.00686	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Imiquimod—skin cancer	0.000756	0.0068	CcSEcCtD
Magnesium salicylate—Tinnitus—Imiquimod—skin cancer	0.000746	0.00671	CcSEcCtD
Magnesium salicylate—Flushing—Imiquimod—skin cancer	0.000743	0.00668	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vismodegib—skin cancer	0.000738	0.00664	CcSEcCtD
Magnesium salicylate—Erythema—Imiquimod—skin cancer	0.000696	0.00626	CcSEcCtD
Magnesium salicylate—Vomiting—Vismodegib—skin cancer	0.000686	0.00617	CcSEcCtD
Magnesium salicylate—Rash—Vismodegib—skin cancer	0.00068	0.00612	CcSEcCtD
Magnesium salicylate—Dermatitis—Vismodegib—skin cancer	0.00068	0.00611	CcSEcCtD
Magnesium salicylate—Hearing impaired—Docetaxel—skin cancer	0.000667	0.006	CcSEcCtD
Magnesium salicylate—Lethargy—Fluorouracil—skin cancer	0.000652	0.00586	CcSEcCtD
Magnesium salicylate—Nausea—Vismodegib—skin cancer	0.000641	0.00576	CcSEcCtD
Magnesium salicylate—Hypotension—Vemurafenib—skin cancer	0.000623	0.0056	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Docetaxel—skin cancer	0.000606	0.00545	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS2—skin cancer	0.000599	0.133	CrCbGaD
Magnesium salicylate—Olsalazine—PTGS2—skin cancer	0.000585	0.13	CrCbGaD
Magnesium salicylate—Oesophagitis—Docetaxel—skin cancer	0.00058	0.00522	CcSEcCtD
Magnesium salicylate—Decreased appetite—Vemurafenib—skin cancer	0.000579	0.00521	CcSEcCtD
Magnesium salicylate—Constipation—Vemurafenib—skin cancer	0.00057	0.00512	CcSEcCtD
Magnesium salicylate—Oedema—Imiquimod—skin cancer	0.000568	0.00511	CcSEcCtD
Magnesium salicylate—Lightheadedness—Docetaxel—skin cancer	0.000568	0.00511	CcSEcCtD
Magnesium salicylate—PTGS1—connective tissue—skin cancer	0.000563	0.0286	CbGeAlD
Magnesium salicylate—Shock—Imiquimod—skin cancer	0.000559	0.00503	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Imiquimod—skin cancer	0.00055	0.00494	CcSEcCtD
Magnesium salicylate—Weight increased—Temozolomide—skin cancer	0.000545	0.0049	CcSEcCtD
Magnesium salicylate—Anorexia—Imiquimod—skin cancer	0.000542	0.00487	CcSEcCtD
Magnesium salicylate—PTGS2—connective tissue—skin cancer	0.000538	0.0274	CbGeAlD
Magnesium salicylate—PTGS1—epithelium—skin cancer	0.000535	0.0272	CbGeAlD
Magnesium salicylate—Hepatitis—Dactinomycin—skin cancer	0.00053	0.00477	CcSEcCtD
Magnesium salicylate—Flushing—Bleomycin—skin cancer	0.000528	0.00474	CcSEcCtD
Magnesium salicylate—Deafness—Docetaxel—skin cancer	0.000515	0.00463	CcSEcCtD
Magnesium salicylate—PTGS2—epithelium—skin cancer	0.000511	0.026	CbGeAlD
Magnesium salicylate—PTGS1—skin of body—skin cancer	0.000509	0.0258	CbGeAlD
Magnesium salicylate—Somnolence—Imiquimod—skin cancer	0.000505	0.00454	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Dactinomycin—skin cancer	0.000501	0.00451	CcSEcCtD
Magnesium salicylate—Dyspepsia—Imiquimod—skin cancer	0.0005	0.0045	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS2—skin cancer	0.000498	0.111	CrCbGaD
Magnesium salicylate—Erythema—Bleomycin—skin cancer	0.000495	0.00445	CcSEcCtD
Magnesium salicylate—Decreased appetite—Imiquimod—skin cancer	0.000494	0.00444	CcSEcCtD
Magnesium salicylate—Flushing—Dactinomycin—skin cancer	0.000492	0.00442	CcSEcCtD
Magnesium salicylate—PTGS2—skin of body—skin cancer	0.000486	0.0247	CbGeAlD
Magnesium salicylate—Pain—Imiquimod—skin cancer	0.000486	0.00437	CcSEcCtD
Magnesium salicylate—Hepatitis—Temozolomide—skin cancer	0.000479	0.00431	CcSEcCtD
Magnesium salicylate—Hallucination—Temozolomide—skin cancer	0.000477	0.00429	CcSEcCtD
Magnesium salicylate—Pruritus—Vemurafenib—skin cancer	0.000472	0.00424	CcSEcCtD
Magnesium salicylate—Lethargy—Docetaxel—skin cancer	0.00047	0.00423	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Imiquimod—skin cancer	0.000468	0.00421	CcSEcCtD
Magnesium salicylate—Epistaxis—Fluorouracil—skin cancer	0.000464	0.00417	CcSEcCtD
Magnesium salicylate—PTGS1—mammalian vulva—skin cancer	0.000464	0.0236	CbGeAlD
Magnesium salicylate—Erythema—Dactinomycin—skin cancer	0.000461	0.00415	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vemurafenib—skin cancer	0.000456	0.0041	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Temozolomide—skin cancer	0.000453	0.00408	CcSEcCtD
Magnesium salicylate—Urticaria—Imiquimod—skin cancer	0.000452	0.00406	CcSEcCtD
Magnesium salicylate—Tinnitus—Temozolomide—skin cancer	0.000447	0.00402	CcSEcCtD
Magnesium salicylate—Flushing—Temozolomide—skin cancer	0.000445	0.004	CcSEcCtD
Magnesium salicylate—Dizziness—Vemurafenib—skin cancer	0.000441	0.00396	CcSEcCtD
Magnesium salicylate—Vomiting—Vemurafenib—skin cancer	0.000424	0.00381	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Docetaxel—skin cancer	0.000421	0.00378	CcSEcCtD
Magnesium salicylate—Rash—Vemurafenib—skin cancer	0.00042	0.00378	CcSEcCtD
Magnesium salicylate—Dermatitis—Vemurafenib—skin cancer	0.00042	0.00377	CcSEcCtD
Magnesium salicylate—Headache—Vemurafenib—skin cancer	0.000418	0.00375	CcSEcCtD
Magnesium salicylate—Erythema—Temozolomide—skin cancer	0.000417	0.00375	CcSEcCtD
Magnesium salicylate—Dysgeusia—Temozolomide—skin cancer	0.000409	0.00367	CcSEcCtD
Magnesium salicylate—ALB—lymph node—skin cancer	0.000408	0.0207	CbGeAlD
Magnesium salicylate—Confusional state—Bleomycin—skin cancer	0.000407	0.00366	CcSEcCtD
Magnesium salicylate—Oedema—Bleomycin—skin cancer	0.000404	0.00363	CcSEcCtD
Magnesium salicylate—Pruritus—Imiquimod—skin cancer	0.000402	0.00362	CcSEcCtD
Magnesium salicylate—PTGS1—female reproductive system—skin cancer	0.000397	0.0202	CbGeAlD
Magnesium salicylate—Nausea—Vemurafenib—skin cancer	0.000396	0.00356	CcSEcCtD
Magnesium salicylate—PTGS2—lymphoid tissue—skin cancer	0.000394	0.02	CbGeAlD
Magnesium salicylate—Diarrhoea—Imiquimod—skin cancer	0.000389	0.0035	CcSEcCtD
Magnesium salicylate—Anorexia—Bleomycin—skin cancer	0.000385	0.00346	CcSEcCtD
Magnesium salicylate—Erythema—Fluorouracil—skin cancer	0.000385	0.00346	CcSEcCtD
Magnesium salicylate—PTGS2—female reproductive system—skin cancer	0.00038	0.0193	CbGeAlD
Magnesium salicylate—Hypotension—Bleomycin—skin cancer	0.000377	0.00339	CcSEcCtD
Magnesium salicylate—Oedema—Dactinomycin—skin cancer	0.000377	0.00339	CcSEcCtD
Magnesium salicylate—Dizziness—Imiquimod—skin cancer	0.000376	0.00338	CcSEcCtD
Magnesium salicylate—Weight increased—Docetaxel—skin cancer	0.000363	0.00326	CcSEcCtD
Magnesium salicylate—Vomiting—Imiquimod—skin cancer	0.000361	0.00325	CcSEcCtD
Magnesium salicylate—Anorexia—Dactinomycin—skin cancer	0.000359	0.00323	CcSEcCtD
Magnesium salicylate—Rash—Imiquimod—skin cancer	0.000358	0.00322	CcSEcCtD
Magnesium salicylate—Dermatitis—Imiquimod—skin cancer	0.000358	0.00322	CcSEcCtD
Magnesium salicylate—Headache—Imiquimod—skin cancer	0.000356	0.0032	CcSEcCtD
Magnesium salicylate—Decreased appetite—Bleomycin—skin cancer	0.000351	0.00316	CcSEcCtD
Magnesium salicylate—Pain—Bleomycin—skin cancer	0.000345	0.0031	CcSEcCtD
Magnesium salicylate—Confusional state—Temozolomide—skin cancer	0.000343	0.00309	CcSEcCtD
Magnesium salicylate—Oedema—Temozolomide—skin cancer	0.000341	0.00306	CcSEcCtD
Magnesium salicylate—Nausea—Imiquimod—skin cancer	0.000338	0.00304	CcSEcCtD
Magnesium salicylate—Epistaxis—Docetaxel—skin cancer	0.000335	0.00301	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Bleomycin—skin cancer	0.000333	0.00299	CcSEcCtD
Magnesium salicylate—PTGS1—head—skin cancer	0.000332	0.0169	CbGeAlD
Magnesium salicylate—Hyperhidrosis—Temozolomide—skin cancer	0.000329	0.00296	CcSEcCtD
Magnesium salicylate—Decreased appetite—Dactinomycin—skin cancer	0.000327	0.00294	CcSEcCtD
Magnesium salicylate—Anorexia—Temozolomide—skin cancer	0.000325	0.00292	CcSEcCtD
Magnesium salicylate—Pain—Dactinomycin—skin cancer	0.000322	0.0029	CcSEcCtD
Magnesium salicylate—Urticaria—Bleomycin—skin cancer	0.000321	0.00288	CcSEcCtD
Magnesium salicylate—Hepatitis—Docetaxel—skin cancer	0.000319	0.00287	CcSEcCtD
Magnesium salicylate—PTGS2—head—skin cancer	0.000317	0.0161	CbGeAlD
Magnesium salicylate—Confusional state—Fluorouracil—skin cancer	0.000316	0.00285	CcSEcCtD
Magnesium salicylate—Oedema—Fluorouracil—skin cancer	0.000314	0.00282	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Dactinomycin—skin cancer	0.00031	0.00279	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS2—skin cancer	0.000306	0.0681	CrCbGaD
Magnesium salicylate—Somnolence—Temozolomide—skin cancer	0.000303	0.00272	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Docetaxel—skin cancer	0.000301	0.00271	CcSEcCtD
Magnesium salicylate—Dyspepsia—Temozolomide—skin cancer	0.0003	0.0027	CcSEcCtD
Magnesium salicylate—Anorexia—Fluorouracil—skin cancer	0.000299	0.00269	CcSEcCtD
Magnesium salicylate—Decreased appetite—Temozolomide—skin cancer	0.000296	0.00266	CcSEcCtD
Magnesium salicylate—Flushing—Docetaxel—skin cancer	0.000296	0.00266	CcSEcCtD
Magnesium salicylate—Hypotension—Fluorouracil—skin cancer	0.000293	0.00264	CcSEcCtD
Magnesium salicylate—Constipation—Temozolomide—skin cancer	0.000291	0.00262	CcSEcCtD
Magnesium salicylate—Pain—Temozolomide—skin cancer	0.000291	0.00262	CcSEcCtD
Magnesium salicylate—Pruritus—Bleomycin—skin cancer	0.000286	0.00257	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Temozolomide—skin cancer	0.000281	0.00252	CcSEcCtD
Magnesium salicylate—Somnolence—Fluorouracil—skin cancer	0.000279	0.00251	CcSEcCtD
Magnesium salicylate—Erythema—Docetaxel—skin cancer	0.000278	0.0025	CcSEcCtD
Magnesium salicylate—Dyspepsia—Fluorouracil—skin cancer	0.000276	0.00248	CcSEcCtD
Magnesium salicylate—Decreased appetite—Fluorouracil—skin cancer	0.000273	0.00245	CcSEcCtD
Magnesium salicylate—Dysgeusia—Docetaxel—skin cancer	0.000272	0.00244	CcSEcCtD
Magnesium salicylate—Urticaria—Temozolomide—skin cancer	0.000271	0.00243	CcSEcCtD
Magnesium salicylate—Pain—Fluorouracil—skin cancer	0.000268	0.00241	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Fluorouracil—skin cancer	0.000259	0.00233	CcSEcCtD
Magnesium salicylate—Diarrhoea—Dactinomycin—skin cancer	0.000258	0.00232	CcSEcCtD
Magnesium salicylate—Vomiting—Bleomycin—skin cancer	0.000257	0.00231	CcSEcCtD
Magnesium salicylate—Rash—Bleomycin—skin cancer	0.000255	0.00229	CcSEcCtD
Magnesium salicylate—Dermatitis—Bleomycin—skin cancer	0.000254	0.00229	CcSEcCtD
Magnesium salicylate—Urticaria—Fluorouracil—skin cancer	0.000249	0.00224	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS2—skin cancer	0.000243	0.054	CrCbGaD
Magnesium salicylate—Pruritus—Temozolomide—skin cancer	0.000241	0.00217	CcSEcCtD
Magnesium salicylate—Nausea—Bleomycin—skin cancer	0.00024	0.00216	CcSEcCtD
Magnesium salicylate—Vomiting—Dactinomycin—skin cancer	0.000239	0.00215	CcSEcCtD
Magnesium salicylate—Rash—Dactinomycin—skin cancer	0.000237	0.00213	CcSEcCtD
Magnesium salicylate—Diarrhoea—Temozolomide—skin cancer	0.000233	0.0021	CcSEcCtD
Magnesium salicylate—PTGS1—lymph node—skin cancer	0.000232	0.0118	CbGeAlD
Magnesium salicylate—Confusional state—Docetaxel—skin cancer	0.000228	0.00205	CcSEcCtD
Magnesium salicylate—Oedema—Docetaxel—skin cancer	0.000227	0.00204	CcSEcCtD
Magnesium salicylate—Dizziness—Temozolomide—skin cancer	0.000225	0.00203	CcSEcCtD
Magnesium salicylate—Nausea—Dactinomycin—skin cancer	0.000224	0.00201	CcSEcCtD
Magnesium salicylate—Shock—Docetaxel—skin cancer	0.000223	0.002	CcSEcCtD
Magnesium salicylate—PTGS2—lymph node—skin cancer	0.000222	0.0113	CbGeAlD
Magnesium salicylate—Pruritus—Fluorouracil—skin cancer	0.000222	0.002	CcSEcCtD
Magnesium salicylate—Vomiting—Temozolomide—skin cancer	0.000217	0.00195	CcSEcCtD
Magnesium salicylate—Anorexia—Docetaxel—skin cancer	0.000216	0.00194	CcSEcCtD
Magnesium salicylate—Rash—Temozolomide—skin cancer	0.000215	0.00193	CcSEcCtD
Magnesium salicylate—Diarrhoea—Fluorouracil—skin cancer	0.000215	0.00193	CcSEcCtD
Magnesium salicylate—Dermatitis—Temozolomide—skin cancer	0.000215	0.00193	CcSEcCtD
Magnesium salicylate—Headache—Temozolomide—skin cancer	0.000213	0.00192	CcSEcCtD
Magnesium salicylate—Hypotension—Docetaxel—skin cancer	0.000212	0.0019	CcSEcCtD
Magnesium salicylate—Dizziness—Fluorouracil—skin cancer	0.000208	0.00187	CcSEcCtD
Magnesium salicylate—Nausea—Temozolomide—skin cancer	0.000202	0.00182	CcSEcCtD
Magnesium salicylate—Somnolence—Docetaxel—skin cancer	0.000201	0.00181	CcSEcCtD
Magnesium salicylate—Vomiting—Fluorouracil—skin cancer	0.0002	0.00179	CcSEcCtD
Magnesium salicylate—Dyspepsia—Docetaxel—skin cancer	0.000199	0.00179	CcSEcCtD
Magnesium salicylate—Rash—Fluorouracil—skin cancer	0.000198	0.00178	CcSEcCtD
Magnesium salicylate—Dermatitis—Fluorouracil—skin cancer	0.000198	0.00178	CcSEcCtD
Magnesium salicylate—Decreased appetite—Docetaxel—skin cancer	0.000197	0.00177	CcSEcCtD
Magnesium salicylate—Headache—Fluorouracil—skin cancer	0.000197	0.00177	CcSEcCtD
Magnesium salicylate—Constipation—Docetaxel—skin cancer	0.000194	0.00174	CcSEcCtD
Magnesium salicylate—Pain—Docetaxel—skin cancer	0.000194	0.00174	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Docetaxel—skin cancer	0.000187	0.00168	CcSEcCtD
Magnesium salicylate—Nausea—Fluorouracil—skin cancer	0.000186	0.00168	CcSEcCtD
Magnesium salicylate—Pruritus—Docetaxel—skin cancer	0.00016	0.00144	CcSEcCtD
Magnesium salicylate—Diarrhoea—Docetaxel—skin cancer	0.000155	0.00139	CcSEcCtD
Magnesium salicylate—Dizziness—Docetaxel—skin cancer	0.00015	0.00135	CcSEcCtD
Magnesium salicylate—Vomiting—Docetaxel—skin cancer	0.000144	0.00129	CcSEcCtD
Magnesium salicylate—Rash—Docetaxel—skin cancer	0.000143	0.00128	CcSEcCtD
Magnesium salicylate—Dermatitis—Docetaxel—skin cancer	0.000143	0.00128	CcSEcCtD
Magnesium salicylate—Headache—Docetaxel—skin cancer	0.000142	0.00128	CcSEcCtD
Magnesium salicylate—Nausea—Docetaxel—skin cancer	0.000135	0.00121	CcSEcCtD
